An attractive approach to replace the destroyed insulin-producing cells (IPCs) is the generation of functional β cells from stem cells. Embryonal carcinoma (EC) stem cells are pluripotent cells which can differentiate into all cell types. The present study was carried out to establish a simple nonselective inductive culture system for generation of IPCs from P19 EC cells by 1-2 weeks old mouse pancreas extract (MPE). Since, mouse pancreatic islets undergo further remodeling and maturation for 2-3 weeks after birth, we hypothesized that the mouse neonatal MPE contains essential factors to induce in vitro differentiation of pancreatic lineages. Pluripotency of P19 cells were first confirmed by expression analysis of stem cell markers, Oct3/4,...
AbstractWe have previously described the derivation of insulin-producing cell lines from mouse embry...
Human pluripotent stem cells represent a potentially unlimited source of functional pancreatic endoc...
AbstractGenerating surrogate insulin-producing cells from embryonic stem cells (ESCs) through in vit...
<div><p>An attractive approach to replace the destroyed insulin-producing cells (IPCs) is the genera...
Transdifferentiation potential of mesenchymal stem cells (MSCs) into insulin-producing cells (IPCs) ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Embryonic stem (ES) cells were used as a model system to understand the signalling events in pancrea...
In Type 1 diabetes, insulin-producing pancreatic cells, or beta cells, are destroyed by an autoimmun...
BACKGROUND New sources of insulin-secreting cells are strongly required for the cure of diabetes. Re...
The capacity for self-renewal and differentiation of human embryonic stem (ES) cells makes them a po...
Human embryonic stem cells can be differentiated into insulin-secreting cells by emulating in vitro ...
Embryonic stem cells possess the ability to differentiate in vitro into a variety of cell lineages, ...
Efficiently obtaining functional pancreatic islet cells derived from human embryonic stem (hES) cell...
Generating surrogate insulin-producing cells from embryonic stem cells (ESCs) through in vitro repli...
We have previously described the derivation of insulin-producing cell lines from mouse embryonic ste...
AbstractWe have previously described the derivation of insulin-producing cell lines from mouse embry...
Human pluripotent stem cells represent a potentially unlimited source of functional pancreatic endoc...
AbstractGenerating surrogate insulin-producing cells from embryonic stem cells (ESCs) through in vit...
<div><p>An attractive approach to replace the destroyed insulin-producing cells (IPCs) is the genera...
Transdifferentiation potential of mesenchymal stem cells (MSCs) into insulin-producing cells (IPCs) ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Embryonic stem (ES) cells were used as a model system to understand the signalling events in pancrea...
In Type 1 diabetes, insulin-producing pancreatic cells, or beta cells, are destroyed by an autoimmun...
BACKGROUND New sources of insulin-secreting cells are strongly required for the cure of diabetes. Re...
The capacity for self-renewal and differentiation of human embryonic stem (ES) cells makes them a po...
Human embryonic stem cells can be differentiated into insulin-secreting cells by emulating in vitro ...
Embryonic stem cells possess the ability to differentiate in vitro into a variety of cell lineages, ...
Efficiently obtaining functional pancreatic islet cells derived from human embryonic stem (hES) cell...
Generating surrogate insulin-producing cells from embryonic stem cells (ESCs) through in vitro repli...
We have previously described the derivation of insulin-producing cell lines from mouse embryonic ste...
AbstractWe have previously described the derivation of insulin-producing cell lines from mouse embry...
Human pluripotent stem cells represent a potentially unlimited source of functional pancreatic endoc...
AbstractGenerating surrogate insulin-producing cells from embryonic stem cells (ESCs) through in vit...